Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Animal Model Market Through 2029?

The market size of the animal model has seen robust growth in the recent past. The projections show an increase from $1.92 billion in 2024 to $2.07 billion in 2025, signifying a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historic period is a result of the increasing use of animal models in biomedical research, rising spending and significant investments in drug discovery and development, a growing emphasis on precision medicine and the widespread use of animal models in the healthcare sector.

The market size of animal models is predicted to experience significant expansion in the upcoming years, escalating to “$2.8 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The predicted surge for the forecasted period can be credited to developments in genetic engineering, an amplified focus on personalized medicine, an increased incidence of chronic diseases, a heightened need for efficient vaccines and therapeutics, plus augmented resources being directed towards biomedical research. Noteworthy trends during the forecasted period incorporate a heightened demand for animal models in the realm of drug discovery and development, escalating occurrences of chronic diseases, physiological resemblances between humans and animals shorten drug development duration, a rising intake of personalized medicine propelling the demand for humanized mice models, and the market experiencing an impressive growth as a result of a rising endorsement of animal models for biomedical research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

What Market Forces Are Driving The Animal Model Sector In 2025 And Beyond?

The animal model market is gearing up for expansion, spurred on by the surge in investment activities linked to pharmaceutical research and development. This domain involves the fusion of scientific concepts and innovation to generate progress in medicine. A rise in inventive therapies and research into treatments for intricate ailments, combined with the expansion of scientific curiosity and commercial prospects in the healthcare sector, is assisting the research and development process. In this respect, animal models assume a crucial role, helping predict the effectiveness, safety, and toxicity of drugs. They also offer insights into biological mechanisms and contribute towards the invention of novel treatments by replicating human physiological responses and disease progression in managed environments. For example, data from the European Federation of Pharmaceutical Industries and Associations, a trade association and lobbying organization based in Belgium, reveals that spending on pharmaceutical research and development amounted to €44,500 ($47,999) in 2022 and €42,533 million ($45,877 million) in 2021 within Europe. As a result, the escalating investments into pharmaceutical research and development are steering the growth of the animal model market.

The animal model market covered in this report is segmented –

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies

3) By Application: Drug Discovery And Development, Basic Research, Other Applications

4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice

2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats

3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs

4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds

5) By Hamsters: Syrian Hamsters, Chinese Hamsters

6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

What Are The Leading Trends And Opportunities In The Animal Model Sector?

Dominant businesses in the animal model market are directing their efforts towards creating cutting-edge products like triple-immunodeficient animal models. These strategic advancements will augment the precision of preclinical investigations, further biomedical research progress, and aid in the designing of new therapies for intricate human diseases. Triple-immunodeficient animal models are specially constructed creatures, typically mice, devoid of three fundamental immune system components, thus becoming indispensable tools in biomedical research, especially in the exploration of human diseases and formulation of new therapeutic techniques. Taking January 2024 as an example, a significant development was the launch of NCG mouse strains by Charles River Laboratories International, Inc., an American pharmaceutical firm. These mice, crucial for oncology research, lack functional/mature T, B, and NK cells and display diminished macrophage and dendritic cell function. These animal models accommodate xenograft cells, tissues, and components of the human immune system. The NCG mouse is optimal for oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. Additionally, NCG mice can be humanized by embedding PBMCs or CD34+ stem cells, hence they are remarkably similar to the human immune system.

Which Firms Are Considered Leaders In The Animal Model Market Space?

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

What Role Do Regional Policies And Investments Play In Animal Model Market Expansion?

North America was the largest region in the animal model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model